Our in vitro and in vivo data demonstrate that OTUB2 functions as a negative regulator of T-lymphocyte-mediated antitumor immunity by modulating PD-L1 stabilization on tumor cells and thereby promotes tumor immune evasion. The gene discussed is OTUB2; the disease is neoplasm.